Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_176009.htm |
| EX-32.1 - EXHIBIT 32.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_176011.htm |
| EX-24.1 - EXHIBIT 24.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_176008.htm |
| EX-23.1 - EXHIBIT 23.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_176007.htm |
| EX-10.28 - EXHIBIT 10.28 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_176004.htm |
| EX-10.27 - EXHIBIT 10.27 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_176346.htm |
| EX-4.3 - EXHIBIT 4.3 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_176385.htm |
| 10-K - FORM 10-K - NAVIDEA BIOPHARMACEUTICALS, INC. | navb20191231_10k.htm |
Exhibit 21.1
Subsidiaries of Navidea Biopharmaceuticals, Inc.
|
Subsidiaries |
Jurisdiction of Incorporation |
Percentage Owned by Registrant |
|
|
Navidea Biopharmaceuticals Limited |
United Kingdom |
100% |
|
|
Macrophage Therapeutics, Inc. |
Delaware, United States |
99.9% |
|